CEMIPLIMAB-RWLC vs PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

Compare CEMIPLIMAB-RWLC (LIBTAYO) and PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH (KEYTRUDA QLEX) — clinical data, side effects, and patient experiences.

CEMIPLIMAB-RWLC

LIBTAYO · Immune Checkpoint Inhibitor

How it works

12.1 Mechanism of Action Binding of the PD-1 ligands PD-L1 and PD-L2 to the PD-1 receptor found on T cells inhibits T-cell proliferation and cytokine production. Upregulation of PD...

Approved for

with no EGFR

ALK or ROS1 aberrations

and is: locally advanced where patients are not candidates for surgical resection or definitive chemoradiation or metastatic. ( 1.3

with no EGFR

IntravenousTablet

PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

KEYTRUDA QLEX, Keytruda · Immune Checkpoint Inhibitor

How it works

12.1 Mechanism of Action Binding of the PD-1 ligands, PD-L1 and PD-L2, to the PD-1 receptor found on T cells, inhibits T cell proliferation and cytokine production. Upregulation of...

Approved for

1 INDICATIONS AND USAGE KEYTRUDA QLEX is a combination of pembrolizumab

a programmed death receptor-1 (PD-1)-blocking antibody

and berahyaluronidase alfa

an endoglycosidase

SubcutaneousTablet

Quick Comparison

CEMIPLIMAB-RWLCPEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

Drug Class

Immune Checkpoint Inhibitor

Route

Intravenous

Subcutaneous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

CEMIPLIMAB-RWLC

Fatigue

1-10%

Rash

1-10%

Shortness of Breath

1-10%

Fever

1-10%

Itching

0.1-1%

Weakness

0.1-1%

Diarrhea

0.1-1%

Nausea

0.1-1%

PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

Diarrhea

1-10%

Fatigue

1-10%

Fever

1-10%

Rash

1-10%

Nausea

1-10%

Decreased Appetite

1-10%

High Blood Pressure

0.1-1%

Weakness

0.1-1%

FDA Warnings

CEMIPLIMAB-RWLC

5 WARNINGS AND PRECAUTIONS Immune-Mediated Adverse Reactions ( 5
1 ) Immune-mediated adverse reactions, which may be severe or fatal, can occur in any organ system or tissue, including the following: immune-mediated pneumonitis, immune-mediated colitis, immune-mediated hepatitis, immune-mediated endocrinopathies, immune-mediated dermatologic adverse reactions, immune-mediated nephritis and renal dysfunction, and solid organ transplant rejection
2 ) Complications of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after being treated with a PD-1/PD-L1 blocking antibody
Advise females of reproductive potential of the potential risk to a fetus and use of effective contraception

PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

5 WARNINGS AND PRECAUTIONS Immune-Mediated Adverse Reactions ( 5
1 ) Immune-mediated adverse reactions, which may be severe or fatal, can occur in any organ system or tissue, including the following: immune-mediated pneumonitis, immune-mediated colitis, immune-mediated hepatitis, immune-mediated endocrinopathies, immune-mediated nephritis with renal dysfunction, immune-mediated dermatologic adverse reactions, and solid organ transplant rejection
2 ) Complications of Allogeneic HSCT: Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after being treated with a PD-1/PD-L1 blocking antibody
Advise females of reproductive potential of the potential risk to a fetus and to use effective method of contraception

Community Sentiment Analysis

Based on 1 Reddit discussions

CEMIPLIMAB-RWLC

positive

1 threads

PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

positive

0 threads

Community-Reported Side Effects

% of discussions mentioning each side effect

Community Discussions

1 Reddit threads analysed for CEMIPLIMAB-RWLC

Overall Sentiment

Mixed

Comparison Threads

Avg Post Score

20 upvotes

Most discussed side effects in community

Muscle Pain (1)

Sexual Dysfunction (1)

Patient Experiences (r/pharmacy, r/AskDocs & more)

Your Morning Coffee: 10/09/2018

# EARNINGS Helen of Troy (HELE) Q2 Adj. EPS USD 1.98 vs. Exp. USD 1.60, revenue USD 393.55mln vs. Exp. USD 349.19mln; raises FY19 Adj. EPS USD 7.65-7.90 vs. Exp. USD 7.62. (Newswires) #DJIA Apple (AAPL) – The behemoth’s 2018 iPad Pro models are to include edge-to-edge displays, Face ID, USB

r/wallstreetbets2017y ago

Muscle Pain

Sexual Dysfunction

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

Community Discussions

No community discussions found for PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH yet.

CEMIPLIMAB-RWLC vs PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH: What You Should Know

Key Differences

Both CEMIPLIMAB-RWLC and PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH belong to the Immune Checkpoint Inhibitor class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. CEMIPLIMAB-RWLC is administered via Intravenous, whereas PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH uses Subcutaneous. Route of administration can affect onset of action and patient adherence.

Safety Considerations

CEMIPLIMAB-RWLC carries 4 FDA warnings. PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

DOSTARLIMAB vs PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH→AVELUMAB vs PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH→CEMIPLIMAB-RWLC vs DOSTARLIMAB→AVELUMAB vs CEMIPLIMAB-RWLC→Nivolumab vs PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH→CEMIPLIMAB-RWLC vs Nivolumab→

Loading comparison data...

CEMIPLIMAB-RWLC vs PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

Compare CEMIPLIMAB-RWLC (LIBTAYO) and PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH (KEYTRUDA QLEX) — clinical data, side effects, and patient experiences.

CEMIPLIMAB-RWLC

LIBTAYO · Immune Checkpoint Inhibitor

How it works

12.1 Mechanism of Action Binding of the PD-1 ligands PD-L1 and PD-L2 to the PD-1 receptor found on T cells inhibits T-cell proliferation and cytokine production. Upregulation of PD...

Approved for

with no EGFR

ALK or ROS1 aberrations

and is: locally advanced where patients are not candidates for surgical resection or definitive chemoradiation or metastatic. ( 1.3

with no EGFR

IntravenousTablet

PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

KEYTRUDA QLEX, Keytruda · Immune Checkpoint Inhibitor

How it works

12.1 Mechanism of Action Binding of the PD-1 ligands, PD-L1 and PD-L2, to the PD-1 receptor found on T cells, inhibits T cell proliferation and cytokine production. Upregulation of...

Approved for

1 INDICATIONS AND USAGE KEYTRUDA QLEX is a combination of pembrolizumab

a programmed death receptor-1 (PD-1)-blocking antibody

and berahyaluronidase alfa

an endoglycosidase

SubcutaneousTablet

Quick Comparison

CEMIPLIMAB-RWLCPEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

Drug Class

Immune Checkpoint Inhibitor

Route

Intravenous

Subcutaneous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

CEMIPLIMAB-RWLC

Fatigue

1-10%

Rash

1-10%

Shortness of Breath

1-10%

Fever

1-10%

Itching

0.1-1%

Weakness

0.1-1%

Diarrhea

0.1-1%

Nausea

0.1-1%

PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

Diarrhea

1-10%

Fatigue

1-10%

Fever

1-10%

Rash

1-10%

Nausea

1-10%

Decreased Appetite

1-10%

High Blood Pressure

0.1-1%

Weakness

0.1-1%

FDA Warnings

CEMIPLIMAB-RWLC

5 WARNINGS AND PRECAUTIONS Immune-Mediated Adverse Reactions ( 5
1 ) Immune-mediated adverse reactions, which may be severe or fatal, can occur in any organ system or tissue, including the following: immune-mediated pneumonitis, immune-mediated colitis, immune-mediated hepatitis, immune-mediated endocrinopathies, immune-mediated dermatologic adverse reactions, immune-mediated nephritis and renal dysfunction, and solid organ transplant rejection
2 ) Complications of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after being treated with a PD-1/PD-L1 blocking antibody
Advise females of reproductive potential of the potential risk to a fetus and use of effective contraception

PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

5 WARNINGS AND PRECAUTIONS Immune-Mediated Adverse Reactions ( 5
1 ) Immune-mediated adverse reactions, which may be severe or fatal, can occur in any organ system or tissue, including the following: immune-mediated pneumonitis, immune-mediated colitis, immune-mediated hepatitis, immune-mediated endocrinopathies, immune-mediated nephritis with renal dysfunction, immune-mediated dermatologic adverse reactions, and solid organ transplant rejection
2 ) Complications of Allogeneic HSCT: Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after being treated with a PD-1/PD-L1 blocking antibody
Advise females of reproductive potential of the potential risk to a fetus and to use effective method of contraception

Community Sentiment Analysis

Based on 1 Reddit discussions

CEMIPLIMAB-RWLC

positive

1 threads

PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH

positive

0 threads

Community-Reported Side Effects

% of discussions mentioning each side effect

Community Discussions

1 Reddit threads analysed for CEMIPLIMAB-RWLC

Overall Sentiment

Mixed

Comparison Threads

Avg Post Score

20 upvotes

Most discussed side effects in community

Muscle Pain (1)

Sexual Dysfunction (1)

Patient Experiences (r/pharmacy, r/AskDocs & more)

Your Morning Coffee: 10/09/2018

r/wallstreetbets2017y ago

Muscle Pain

Sexual Dysfunction

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

Community Discussions

No community discussions found for PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH yet.

CEMIPLIMAB-RWLC vs PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.